TABLE OF CONTENTS
1. Indian Pharmaceutical Industry.........................................................................................................3
Overview...........................................................................................................................................3
1.1 Industry share and major players.................................................................................................3
1.2 Export trends...............................................................................................................................3
1.4 Opportunities and future potential...............................................................................................4
1.5 Indian Government initiatives......................................................................................................5
2. Hypothesis.........................................................................................................................................5
3. About the Companies.......................................................................................................................5
3.1 Sun Pharmaceutical Industries Ltd..............................................................................................5
3.2 Ranbaxy Laboratories..................................................................................................................6
4. Need of the Merger............................................................................................................................6
5. Details of Transaction........................................................................................................................8
6. Anticipated Outcomes & Synergies for Sun Pharma.......................................................................10
7. Issues Related To The Merger.........................................................................................................10
7.1 Issues: Sun Pharma faced with in return of the deal..................................................................11
7.2 Post Deal Challenges:................................................................................................................11
8. Post-Acquisition Stage....................................................................................................................13
8.1 Planned measures......................................................................................................................13
8.2 Strategy to build synergies.........................................................................................................14
9. Post-merger repercussions...............................................................................................................15
10. Conclusion.....................................................................................................................................16
References:..........................................................................................................................................18
2

+13062052269

info@desklib.com

Submitted by: Group 1 Ritam Khanna F028 Saundarya Mehra F038 Nahid Seliya F050 Vatsal Shah F054 Himanshu Sharma F054 Shantanu Sharma F057 August 2019

Contribute Materials